A Agilent Technologies Inc.

Agilent Receives Two Scientists’ Choice Awards

(NYSE: A) today announced that two of the company’s instruments have received Scientists’ Choice awards. The Agilent 8890 GC system won for Best New Separations Product, and the Agilent InfinityLab LC/MSD iQ system won for Best New Spectroscopy Product.

SelectScience, an independent, expert-led scientific review, began the Scientists’ Choice Awards in 2007 to enable scientists to voice their opinions on the best laboratory products. Each year, SelectScience invites members to nominate their favorite products in various categories. The awards are based on member votes and recognize the innovation and impact these products have had on the market.

“We are delighted to have received these awards,” said Jacob Thaysen, senior vice president, Agilent and President, Life Sciences and Applied Markets Group (LSAG). “We work hard to create innovative solutions to meet the evolving needs of our customers—particularly the need to simplify their workflows, improve productivity, and reap the benefits of greater connectivity. These awards are a recognition of our continued investment in research and development for the future of the laboratory.”

Both Agilent systems integrate next-generation intelligence, including diagnostic tools and software that ensure pro-active maintenance for maximum uptime and greater sample throughput.

The award for the 8890 reflects the value chromatographers see in these state-of-the-art smart connected technologies. Combined with the system’s flexible configurability, the 8890 is able to meet chromatographic needs today and well into the future.

This is the third award for the InfinityLab LC/MSD iQ system since launching in 2019, a reflection of how the system’s ease of use makes LC/MS technology accessible to chromatographers. The system has previously been recognized by The Analytical Scientist and The Medicine Maker 2019 Innovation awards.

Winners were announced at Pittcon 2020, the world’s largest annual conference and exposition on laboratory science, in Chicago, Illinois.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets. Now in its 20th year as an independent company delivering insight and innovation toward improving the quality of life, Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.16 billion in fiscal 2019 and employs 16,300 people worldwide. Information about Agilent is available at . To receive the latest Agilent news, subscribe to the Agilent . Follow Agilent on , , and .

EN
12/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agilent Technologies Inc.

Agilent Technologies, Inc.: Update to credit analysis

Our credit view of this issuer reflects its low financial leverage, against its high proportion of revenue from costly equipment sales, which has exposure to cyclical demand fluctuations

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Agilent Technologies, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 11 December 2025 in which we reassessed the appropriateness of the ratings in th...

Agilent Technologies Inc: 1 director

A director at Agilent Technologies Inc sold 2,600 shares at 149.812USD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

6550-6569 S&P 500 Support Holding For Now After 5.5-months, the S&P 500 (SPX) has now failed to break and stay below the its 20-day MA. However, 6569 has been our level that needs to break in order for us to have confidence that a pullback has begun; SPX made a low of 6551 on Friday (less than 20 points or 0.3% from our 6569 level), meaning it was not a decisive breakdown (in time or price). As a result, our near-term bullish outlook since our 4/22/25 Compass remains intact, and it will stay t...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch